Justice Department reclassifies state-licensed medical marijuana to Schedule III, easing research and industry restrictions
SUMMARY
On April 23, 2026, the Department of Justice, led by Acting Attorney General Todd Blanche, reclassified FDA-approved and state-licensed medical marijuana from Schedule I to Schedule III under federal law, a move that eases restrictions on research, allows tax deductions for cannabis businesses, and advances a policy review initiated under President Joe Biden. President Donald Trump directed the acceleration of the process via an executive order in December 2025. The change does not legalize marijuana federally, and the Drug Enforcement Administration will hold a final administrative hearings on June 29. While supported by industry and public health advocates, the move faces opposition from some Republican lawmakers. Nearly half of U.S. states have legalized marijuana in some form, and the reclassification is expected to impact research, taxation, and business operations, though interstate commerce remains restricted.
The headline and summary are AI-generated to reduce bias
Justice Department reclassifies state-licensed medical marijuana to Schedule III, easing research and industry restrictions
SUMMARY
On April 23, 2026, the Department of Justice, led by Acting Attorney General Todd Blanche, reclassified FDA-approved and state-licensed medical marijuana from Schedule I to Schedule III under federal law, a move that eases restrictions on research, allows tax deductions for cannabis businesses, and advances a policy review initiated under President Joe Biden. President Donald Trump directed the acceleration of the process via an executive order in December 2025. The change does not legalize marijuana federally, and the Drug Enforcement Administration will hold a final administrative hearings on June 29. While supported by industry and public health advocates, the move faces opposition from some Republican lawmakers. Nearly half of U.S. states have legalized marijuana in some form, and the reclassification is expected to impact research, taxation, and business operations, though interstate commerce remains restricted.
The headline and summary are AI-generated to reduce bias
Sources broadly agree on core facts but diverge in emphasis: some highlight political conflict (Daily Mail), others economic impact (New York Post, RTÉ), scientific inquiry (USA Today), or bureaucratic process (CNN). CNN provides the most complete context, including historical background, internal delays, and political tensions. USA Today is narrowly focused on public education, while Reuters offers minimal detail. Neutral framing requires balancing administrative, medical, economic, and political dimensions without attributing sole credit or controversy.
Justice Department jumpstarts process to reclassify marijuana as a less dangerous drug
Article Framing: Bureaucratic breakthrough after political pressure
Tone: Investigative, contextual
Trump, marijuana and what to know about THC
Article Framing: Regulatory and public health reform
Tone: Neutral, informative
Trump administration moves to reclassify marijuana to schedule III drug
Article Framing: Part of broader executive push on drug policy reform
Tone: Contextual, slightly promotional
more event articles by score ↓ collapse ↑
DOJ reclassifies certain marijuana products as a less-dangerous drug
Article Framing: Minimalist administrative update
Tone: Terse, factual
US reclassifies some marijuana products as less
Article Framing: Industry-friendly policy transformation
Tone: Enthusiastic, pro-industry
Trump reclassifies marijuana in bold move angering some of his closest Republican allies
Article Framing: Politically contentious executive action
Tone: Dramatic, conflict-oriented
Trump administration eases regulation on state-licensed marijuana
Article Framing: Regulatory and public health reform
Tone: Neutral, informative
Trump is sending a dangerously wrong message on weed
Article Framing: Executive-driven economic and research liberation
Tone: Positive, promotional
Trump admin rewrites the rulebook on weed with reclassification — making research and banking much easier
Article Framing: Executive-driven economic and research liberation
Tone: Positive, promotional
ADVANCED ANALYSIS
WHAT SOURCES AGREE ON
1 / 6- ✓ The Department of Justice, under Acting Attorney General Todd Blanche, signed an order on April 23, 2026, reclassifying FDA-approved and state-licensed medical marijuana from Schedule I to Schedule III under the Controlled Substances Act.
- ✓ This reclassification does not legalize marijuana federally but eases federal restrictions on research, taxation, and industry operations.
- ✓ Schedule I drugs are defined as having no accepted medical use and high potential for abuse (e.g., heroin, LSD); Schedule III drugs are considered to have a moderate to low potential for dependence (e.g., ketamine, Tylenol with codeine).
- ✓ President Donald Trump issued an executive order in December 2025 directing the Justice Department to expedite the reclassification process.
- ✓ The Drug Enforcement Administration (DEA) will hold an administrative hearing on the broader reclassification of marijuana, scheduled for June 29, 2026.
- ✓ Marijuana remains illegal under federal law, and the change does not affect interstate transport or automatically legalize recreational use.
- ✓ The move follows earlier efforts initiated under President Joe Biden to review marijuana’s classification.
USA Today
Daily Mail
USA Today
New York Post
CNN
RTÉ
The Guardian
CNN
USA Today
Daily Mail
New York Post
RTÉ
The Guardian
CNN
New York Post
RTÉ
The Guardian
USA Today
Daily Mail
Reuters
RTÉ
USA Today
USA Today
CNN
The Guardian
CNN
USA Today
Daily Mail
New York Post
The Guardian
Justice Department jumpstarts process to reclassify marijuana as a less dangerous drug
Trump, marijuana and what to know about THC
Trump administration moves to reclassify marijuana to schedule III drug
DOJ reclassifies certain marijuana products as a less-dangerous drug
US reclassifies some marijuana products as less
Trump reclassifies marijuana in bold move angering some of his closest Republican allies
Trump administration eases regulation on state-licensed marijuana
Trump is sending a dangerously wrong message on weed
Trump admin rewrites the rulebook on weed with reclassification — making research and banking much easier